Xylem Inc.
XYL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8,562 | $7,364 | $5,522 | $5,195 |
| % Growth | 16.3% | 33.4% | 6.3% | – |
| Cost of Goods Sold | $5,350 | $4,647 | $3,438 | $3,220 |
| Gross Profit | $3,212 | $2,717 | $2,084 | $1,975 |
| % Margin | 37.5% | 36.9% | 37.7% | 38% |
| R&D Expenses | $230 | $232 | $206 | $204 |
| G&A Expenses | $1,911 | $1,757 | $1,367 | $1,179 |
| SG&A Expenses | $1,911 | $1,757 | $1,367 | $1,179 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $62 | $76 | -$111 | $7 |
| Operating Expenses | $2,203 | $2,065 | $1,462 | $1,390 |
| Operating Income | $1,009 | $652 | $622 | $585 |
| % Margin | 11.8% | 8.9% | 11.3% | 11.3% |
| Other Income/Exp. Net | $78 | -$17 | -$182 | -$74 |
| Pre-Tax Income | $1,087 | $635 | $440 | $511 |
| Tax Expense | $197 | $26 | $85 | $84 |
| Net Income | $890 | $609 | $355 | $427 |
| % Margin | 10.4% | 8.3% | 6.4% | 8.2% |
| EPS | 3.67 | 2.81 | 1.97 | 2.37 |
| % Growth | 30.6% | 42.6% | -16.9% | – |
| EPS Diluted | 3.65 | 2.79 | 1.96 | 2.35 |
| Weighted Avg Shares Out | 243 | 217 | 180 | 180 |
| Weighted Avg Shares Out Dil | 244 | 218 | 181 | 182 |
| Supplemental Information | – | – | – | – |
| Interest Income | $28 | $28 | $16 | $7 |
| Interest Expense | $44 | $49 | $50 | $76 |
| Depreciation & Amortization | $562 | $436 | $236 | $245 |
| EBITDA | $1,693 | $1,120 | $726 | $832 |
| % Margin | 19.8% | 15.2% | 13.1% | 16% |